Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Go back to Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
(NASDAQ: KRYS) Delayed: 322.17 -3.25 (1%)
Previous Close $325.42    52 Week High $ 
Open $324.31    52 Week Low $ 
Day High $327.35    P/E N/A 
Day Low $319.83    EPS $ 
Volume 468,869